Please use this identifier to cite or link to this item:
Title: Clinical practice and pricing insights into medicine access intelligence
Authors: Cassar, Stefan
Wirth, Francesca
Serracino-Inglott, Anthony
Keywords: Drug accessibility -- Malta
Drug accessibility -- Malta -- Case studies
Pharmaceutical policy -- Malta
Drugs -- Prices
Issue Date: 2018-09
Publisher: University of Malta. Department of Pharmacy
Citation: Cassar, S., Wirth, F., & Serracino-Inglott, A. (2018, September). Clinical practice and pricing insights into medicine access intelligence. Poster session presented at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences, Glasgow, United Kingdom.
Abstract: A poster presentation regarding clinical practice and pricing insights into medicine access intelligence. Introduction: The World Health Organisation defines medicine access as “having medicines continuously available and affordable at private or public health facilities or medicine outlets that are within one hour walk of the population”. Access to medicines depends on five factors; availability, accessibility, affordability, quality and acceptability. Aims: • To reflect on scenarios that challenge access to medicine. • To identify factors that are causing access barriers. • To develop pharmaceutical systems to avoid such medicine access barriers in a cost-effective manner.
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Clinical_practice_and_pricing_insights_into_medicine_access_intelligence_2018.pdf332.49 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.